
CAS Name: N,N-Dimethyl-N'-(phenylmethyl)-N'-2-pyridinyl-1,2-ethanediamine
Additional Names: 2-[benzyl(2-dimethylaminoethyl)amino]pyridine; N-benzyl-N',N'-dimethyl-N-(2-pyridyl)ethylenediamine; ...
Literature References: Prepn: C. P. Huttrer et al., J. Am. Chem. Soc. 68, 1999 (1946); C. Djerassi et al., US 2406594 (1946 to Ciba); R. J. Horclois, US 2502151 (1950 to Rhône-Poulenc). Crystal structure: M. Parvez, Acta Crystallogr. C43, 1408 (1987). Toxicity studies: D. P. Waller et al., Clin. Toxicol. 16, 17 (1980). Comprehensive description: H. G. Piskorik, Anal. Profiles Drug Subs. 14, 108-133 (1985).
CAS Name: 2,6-Dimethyl-1,3-dioxan-4-ol acetate
Additional Names: 6-acetoxy-2,4-dimethyl-m-dioxane; 2,6-dimethyl-m-dioxan-4-yl acetate; acetomethoxane
Trademarks: Dioxin (obsolete); Giv-Gard ...
Literature References: Prepn: C. S. Marvel et al., J. Org. Chem. 4, 252 (1939); Späth et al., Ber. 76, 57 (1943). Description: Am. Perfum. Cosmet. 77, no. 12, 32-34 (1962), C.A. 58, 8848c (1963).
CAS Name: a-Phenyl-a-propoxybenzeneacetic acid 1-methyl-4-piperidinyl ester
Additional Names: a,a-diphenyl-a-propoxyacetic acid 1-methyl-4-piperidyl ester; 1-methyl-4-piperidyl diphenylpropoxya...
Literature References: Prepn: C. Starke et al., DD 106643 (1974), C.A. 82, 155841s (1975). GC-MS determn in plasma and urine: T. Marunaka et al., J. Chromatogr. 420, 43 (1987). Pharmacology: A. Haruno, Arzneim.-Forsch. 42, 815, 1459 (1992). Acute toxicity: K. Yamashita et al., J. Toxicol. Sci. 14, Suppl. 2, 1 (1989), C.A. 112, 172060 (1990). Clinical pharmacokinetics: C. Müller et al., Eur. J. Drug Metab. Pharmacokinet. 18, 265 (1993). Clinical trial in urinary incontinence: D. Mazur et al., Urologe A33, 447 (1994).
CAS Name: 3,4-Dihydro-3-(phenylmethyl)-6-(trifluoromethyl)-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide
Additional Names: 3-benzyl-6-trifluoromethyl-3,4-dihydro-7-sulfamoyl-2H-1,2,4-benz...
Literature References: Prepn: C. T. Holdrege et al., J. Am. Chem. Soc. 81, 4807 (1959); F. Lund, W. O. Godtfredsen, GB 863474; eidem, US 3392168 (1961, 1968 both to Lövens Kemiske Fabrik). Comprehensive description: K. Florey, F. M. Russo-Alesi, Anal. Profiles Drug Subs. 5, 1-19 (1976).
CAS Name: [1,2-Diarsenediylbis[(6-hydroxy-3,1-phenylene)imino]]bismethanesulfonic acid disodium salt
Additional Names: disodium 3,3'-diamino-4,4'-dihydroxyarsenobenzene N-dimethylenesulfonate; ...
Literature References: Prepn: C. Voegtlin, J. M. Johnson, J. Am. Chem. Soc. 44, 2573 (1922); W. J. C. Dyke, H. King, J. Chem. Soc. 1935, 1745.
CAS Name: 4-Amino-N-(4,6-dimethyl-2-pyrimidinyl)benzenesulfonamide
Additional Names: N1-(4,6-dimethyl-2-pyrimidinyl)sulfanilamide; N1-(4,6-dimethyl-2-pyrimidyl)sulfanilamide; 4,6-dimethyl-2-sul...
Literature References: Prepn: Caldwell et al., J. Am. Chem. Soc. 63, 2188 (1941); Roblin et al., ibid. 64, 567 (1942); Weisner, Katscher, GB 546158 (1942 to Ward, Blenkinsop); Sprague, US 2407966 (1946 to Sharp Dohme). Alternate prepn: Haworth, Rose, GB 552887 (1943 to I.C.I.); Garzia, US 3119818 (1964 to Ist. Chemioterap. Ital.). Anticoccidiosis activity: Zarin, Feodorova, C.A. 66, 114, 435p-436q (1967). Metabolic studies: Turco et al., Clin. Pharmacol. Ther. 7, 603 (1966); Parker et al., Hum. Hered. 19, 402 (1969). Solubility studies: Shkadova et al., Farm. Zh. (Kiev) 24, 39 (1969). Acute toxicity: B. Bobranski et al., Arch. Immunol. Ther. Exp. 16, 804 (1968). Comprehensive description: C. Papostephanou, M. Frantz, Anal. Profiles Drug Subs. 7, 401-422 (1978).
CAS Name: 2-Hydroxy-N,N,N,N',N',N'-hexamethyl-1,3-propanediaminium diiodide
Additional Names: (2-hydroxytrimethylene)bis[trimethylammonium] iodide; 1,3-bis(trimethylamino)-2-propanol diiodide; ...
Literature References: Prepn: Callsen, US 1526627 (1925).
CAS Name: (11b,16a)-21-(Acetyloxy)-3-(2-chloroethoxy)-9-fluoro-11-hydroxy-16,17-[(1-methylethylidene)bis(oxy)]-20-oxopregna-3,5-diene-6-carboxaldehyde
Additional Names: 3-(2-chloroethoxy)-9-flu...
Literature References: Prepn: Camerino et al., FR 1396602 C.A. 63, 5713c (1965); NL 6508458; US 3314945 (1965, 1966, 1967 all to Farmitalia); Baldratti et al., Experientia 22, 468 (1966). Pharmacology: Suchowsky, Baldratti, Proc. 2nd Int. Congr. Horm. Steroids 1966, L. Martini, F. Fraschini, M. Motta, Eds. (Excerpta Medica Found., Amsterdam, 1967) pp 536-540; Tajima, Otsu, Jpn. J. Pharmacol. 62, 115 (1966), C.A. 67, 72329v (1967); Baldratti et al., Arzneim.-Forsch. 21, 1533 (1971). Toxicity studies: Bertazzoli et al., J. Eur. Toxicol. 4, 88 (1971).
CAS Name: (17b)-4,17-Dihydroxyestr-4-en-3-one
Additional Names: 4-hydroxy-19-nortestosterone; 19-norandrost-4-ene-4,17b-diol-3-one
Percent Composition: C 74.45%, H 9.02%, O 16.53%
Literature References: Prepn: Camerino et al., US 2999870 and US 3145201 (1961, 1964, both to Farmitalia). Prepn of the cypionate: Camerino, Patelli, GB 879622 and US 3020295 (1961, 1962, both to Farmitalia).
CAS Name: (17b)-4-Chloro-17-hydroxyandrost-4-en-3-one
Additional Names: 4-chlorotestosterone
Percent Composition: C 70.68%, H 8.43%, Cl 10.98%, O 9.91%
Literature References: Prepn: Camerino et al., Farmaco Ed. Sci. 11, 586 (1956); eidem, J. Am. Chem. Soc. 78, 3540 (1956); Ringold et al., J. Org. Chem. 21, 1432 (1956); Camerino, US 2953582 (1960 to Farmitalia); Julian, Printy, US 2933510 (1960 to Julian Labs.). Clinical pharmacology of the acetate: Molinatti et al., Folia Endocrinol. 14, 528 (1961); Krueskemper, Morgner, Int. Z. Klin. Pharmakol. Ther. Toxikol. 1, 455 (1968).
即日起可免费注册成为会员, 建立企业产品库, 免费上传产品目录, 企业介绍等. 让你的产品直接呈现给客户.
试运营阶段,所有广告业务5折优惠
